Evicenter
MarkdownMedical informationP&T meetings
Palazestrant (OP-1250)

Previously treated ER-positive HER2-negative advanced or metastatic breast cancer

Manufacturer
Olema Oncology
Last updated
256 sources

Product information and disease descriptionProduct descriptionProduct information

Effect of Palazestrant on quality measures

6 evidence topics · 6 sources

Product-specific effect on quality measures

No evidence found.